BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

447 related articles for article (PubMed ID: 11716066)

  • 1. Biological mechanisms of glioma invasion and potential therapeutic targets.
    Tysnes BB; Mahesparan R
    J Neurooncol; 2001 Jun; 53(2):129-47. PubMed ID: 11716066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pten signaling in gliomas.
    Knobbe CB; Merlo A; Reifenberger G
    Neuro Oncol; 2002 Jul; 4(3):196-211. PubMed ID: 12084351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of matrix metalloproteinase genes in glioma invasion: co-dependent and interactive proteolysis.
    VanMeter TE; Rooprai HK; Kibble MM; Fillmore HL; Broaddus WC; Pilkington GJ
    J Neurooncol; 2001 Jun; 53(2):213-35. PubMed ID: 11716072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Migration and invasion in brain neoplasms.
    Bolteus AJ; Berens ME; Pilkington GJ
    Curr Neurol Neurosci Rep; 2001 May; 1(3):225-32. PubMed ID: 11898522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunocytochemical mapping of the phosphatase and tensin homolog (PTEN/MMAC1) tumor suppressor protein in human gliomas.
    Fults D; Pedone C
    Neuro Oncol; 2000 Apr; 2(2):71-9. PubMed ID: 11303623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Membrane-type matrix metalloproteinases (MT-MMPs): expression and function during glioma invasion.
    Fillmore HL; VanMeter TE; Broaddus WC
    J Neurooncol; 2001 Jun; 53(2):187-202. PubMed ID: 11716070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular approaches to brain tumour invasion.
    Günther W; Skaftnesmo KO; Arnold H; Terzis AJ
    Acta Neurochir (Wien); 2003 Dec; 145(12):1029-36. PubMed ID: 14663559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acquisition of the glioblastoma phenotype during astrocytoma progression is associated with loss of heterozygosity on 10q25-qter.
    Fujisawa H; Kurrer M; Reis RM; Yonekawa Y; Kleihues P; Ohgaki H
    Am J Pathol; 1999 Aug; 155(2):387-94. PubMed ID: 10433932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The functional role of tumor suppressor genes in gliomas: clues for future therapeutic strategies.
    Fueyo J; Gomez-Manzano C; Yung WK; Kyritsis AP
    Neurology; 1998 Nov; 51(5):1250-5. PubMed ID: 9818841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Translational research strategies applied to glioma therapeutics.
    Berger MS; Keles GE
    Clin Neurosurg; 2004; 51():203-6. PubMed ID: 15571146
    [No Abstract]   [Full Text] [Related]  

  • 11. Suppression of invasion in human U87 glioma cells by adenovirus-mediated co-transfer of TIMP-2 and PTEN gene.
    Lu W; Zhou X; Hong B; Liu J; Yue Z
    Cancer Lett; 2004 Oct; 214(2):205-13. PubMed ID: 15363547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterisation of molecular alterations in microdissected archival gliomas.
    Walker C; Joyce KA; Thompson-Hehir J; Davies MP; Gibbs FE; Halliwell N; Lloyd BH; Machell Y; Roebuck MM; Salisbury J; Sibson DR; Du Plessis D; Broome J; Rossi ML
    Acta Neuropathol; 2001 Apr; 101(4):321-33. PubMed ID: 11355303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyaluronate receptors mediating glioma cell migration and proliferation.
    Akiyama Y; Jung S; Salhia B; Lee S; Hubbard S; Taylor M; Mainprize T; Akaishi K; van Furth W; Rutka JT
    J Neurooncol; 2001 Jun; 53(2):115-27. PubMed ID: 11716065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glioma cell invasion: regulation of metalloproteinase activity by TGF-beta.
    Wick W; Platten M; Weller M
    J Neurooncol; 2001 Jun; 53(2):177-85. PubMed ID: 11716069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biology and treatment of malignant glioma.
    Prados MD; Levin V
    Semin Oncol; 2000 Jun; 27(3 Suppl 6):1-10. PubMed ID: 10866344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional evaluation of p53 and PTEN gene mutations in gliomas.
    Kato H; Kato S; Kumabe T; Sonoda Y; Yoshimoto T; Kato S; Han SY; Suzuki T; Shibata H; Kanamaru R; Ishioka C
    Clin Cancer Res; 2000 Oct; 6(10):3937-43. PubMed ID: 11051241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell-extracellular matrix interaction in glioma invasion.
    Goldbrunner RH; Bernstein JJ; Tonn JC
    Acta Neurochir (Wien); 1999; 141(3):295-305; discussion 304-5. PubMed ID: 10214487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Roles of the functional loss of p53 and other genes in astrocytoma tumorigenesis and progression.
    Nozaki M; Tada M; Kobayashi H; Zhang CL; Sawamura Y; Abe H; Ishii N; Van Meir EG
    Neuro Oncol; 1999 Apr; 1(2):124-37. PubMed ID: 11550308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thromboxane synthase regulates the migratory phenotype of human glioma cells.
    Giese A; Hagel C; Kim EL; Zapf S; Djawaheri J; Berens ME; Westphal M
    Neuro Oncol; 1999 Jan; 1(1):3-13. PubMed ID: 11550298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PTEN mutation, EGFR amplification, and outcome in patients with anaplastic astrocytoma and glioblastoma multiforme.
    Smith JS; Tachibana I; Passe SM; Huntley BK; Borell TJ; Iturria N; O'Fallon JR; Schaefer PL; Scheithauer BW; James CD; Buckner JC; Jenkins RB
    J Natl Cancer Inst; 2001 Aug; 93(16):1246-56. PubMed ID: 11504770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.